Chiropractors in Emmett, ID Accepting Medicare

7 Chiropractors found. Showing 1 - 7

Dr. Jason Christopher Schreck, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 701 S Washington Ave, Emmett, ID 83617 Phone: 208-365-1392    Fax: 208-365-4950

Schreck Chiropractic And Wellness Chiropractor Medicare: Medicare Enrolled Practice Location: 701 S Washington Ave, Emmett, ID 83617 Phone: 208-365-1392    Fax: 208-365-4950

Gardner Chiropractic Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 518 S Washington Ave, Emmett, ID 83617 Phone: 208-365-2024    Fax: 208-365-2046

Dr. Aaron R Gardner, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 518 S Washington Ave, Emmett, ID 83617 Phone: 208-365-2024    Fax: 208-365-2046

Dr. Melinda Ann Sauvage, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 780 Clifford Dr, Emmett, ID 83617 Phone: 509-994-3969

Mikeal Bruce Nave, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 108 E 6th St, Emmett, ID 83617 Phone: 208-365-6300    Fax: 208-365-6309

Daniel Michael Pewe, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 288 Highway 16 Ste 101, Emmett, ID 83617 Phone: 208-365-2225    Fax: 208-365-2225

News Archive

More research needed to assess psychological debriefing in schools

There is no evidence to support psychological debriefing in schools after traumatic events such as violence, suicides and accidental death, which runs counter to current practice in some Canadian school jurisdictions, according to a commentary http://www.cmaj.ca/embargo/cmaj091621.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca .

Prevention of osteoporosis might lie in vitamin D levels

Sixty-year-old Darlene Yates has had two hip replacements, a knee replacement and this past year shattered her left femur while she was walking in her neighborhood.

Apricus receives $733,437 grants under QTDP program

Apricus Biosciences, Inc., today announced the award of three grants totaling $733,437 under the Qualifying Therapeutic Discovery Project program for PrevOnco, RayVa and Femprox which are the Company's development programs in cancer, autoimmune/cardiovascular and female sexual dysfunction, respectively.

Blood test reveals more gene mutations in cancer than traditional tumor biopsy

A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.

Intarcia Therapeutics announces positive top-line results from ITCA 650 Phase 3 FREEDOM-2 clinical trial

Intarcia Therapeutics, Inc. today announced positive top-line results from its 52-week Phase 3 FREEDOM-2 clinical trial to determine the comparative efficacy of the company's late-stage investigational candidate ITCA 650 to Merck's Januvia in reducing HbA1c in patients with type 2 diabetes following a year of treatment.

Read more Medical News

› Verified 4 days ago